基于网络药理学与实验验证探讨参附注射液抑制炎症及预防脓毒症心肌细胞凋亡的机制
该研究结合网络药理学与小鼠实验,探讨参附注射液治疗脓毒症的心肌保护机制。共使用198只小鼠,通过盲肠结扎穿孔术(CLP)建立脓毒症模型。结果显示参附注射液可提高7天生存率、改善心功能,其机制可能与抑制炎症及凋亡相关。
要点
- 参附注射液可提高脓毒症小鼠7天生存率并改善左室射血分数(LVEF)。
- 网络药理学提示IL2、BCL2、BAX、CASP7等为核心靶点,凋亡与TNF信号通路富集。
- 实验验证显示参附注射液减少心肌凋亡细胞,调节Bcl-2、Bid、t-Bid、Cyc等蛋白表达。
核心结论
- 参附注射液主要通过抑制炎症和凋亡,改善脓毒症小鼠的生存率与心功能。
研究设计与样本
- 实验共使用198只小鼠,采用盲肠结扎穿孔术(CLP)建立脓毒症模型。
- 通过生存分析筛选参附注射液剂量与治疗时间窗,并采用超声心动图评价心功能。
- 结合网络药理学预测靶点与通路,并用H&E、TUNEL染色、Western blot及透射电镜验证。
主要发现
- Kaplan-Meier生存分析显示,与CLP小鼠相比,参附注射液显著提高7天生存率(P < 0.05)。
- 超声心动图分析发现,CLP小鼠LVEF和FS较Sham小鼠显著降低,而参附注射液显著提高LVEF(P < 001)。
- 网络药理学分析显示,度值较高的潜在靶点包括IL2、BCL2、BAX、CASP7、BID、CASP8;度值较高的通路包括凋亡、TNF信号通路、线粒体通路凋亡、PI3K-AKT信号通路。
- 与CLP组相比,参附注射液治疗显著减少凋亡细胞数量(P < 0.01)。
- Western blot分析表明,CLP手术较Sham组降低抗凋亡蛋白Bcl-2表达、提高促凋亡蛋白Bid、t-Bid、Cyc表达(P < 0.01);参附注射液治疗显著抑制Bid、t-Bid、Cyc及Caspase-9表达。
临床怎么用
- 参附注射液在脓毒症小鼠中显示出提高生存率与改善心功能的作用,机制涉及抑制炎症与凋亡。
- 网络药理学提示的靶点与通路(如凋亡、TNF信号通路、PI3K-AKT信号通路)可为后续机制研究提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Shenfu injection(SFI), as a famous classical Chinese patent medicine injection for the treatment of sepsis, has achieved good curative effects in clinical practice. However, its specific ingredients and molecular mechanisms is still unclear. AIM OF THE STUDY: To analyze the effective ingredients and molecular mechanisms of SFI in the treatment of sepsis via network pharmacology technology and experimental validation. MATERIALS AND METHODS: A total of 198 mice were used in this experiment. Septic mice model was performed by cecal ligation and puncture (CLP). First, Survival rates were calculted to screen the dosage and the treatment time window of SFI. Cardiac function was evaluated by echocardiography. The potential targets and pathways of SFI in the treatment of sepsis were predicted by network pharmacology. Myocardial tissue samples were harvest from different groups after CLP surgery. Hematoxylin-eosin (H&E) and TUNEL staining were used to examine the injury of heart. Western-blot analysis was performed to determine the protein expression of apoptosis. Meanwhile, the structural changes and mitochondrial membrane potential in the mitochondria of cardiomyocytes were also observed by transmission electron microscopy. RESULTS: The Kaplan-Meier survival analysis showed that SFI significantly improved the 7-day survival rate as compared with that of CLP mice (P < 0.05). Echocardiography analysis found that LVEF and FS were significantly reduced in CLP mice compared with Sham mice, while SFI significantly increased LVEF (P < 001). Network pharmacology analysis indicated that the potential targets with higher degrees include IL2, BCL2, BAX, CASP7, BID, CASP8. Pathways with higher degrees include apoptosis, TNF signaling pathway, mitochondrial pathway apoptosis, PI3K-AKT signaling pathway. SFI treatment markedly attenuated the quantity of apoptotic cells as compared with the CLP group (P < 0.01). Western blot analysis indicated that CLP surgery decreased the expression of Bcl-2 (anti-apoptotic) but improved the protein expression of Bid, t-Bid, Cyc (pro-apoptotic) as compared with the Sham group (P < 0.01). While, SFI treatment markedly prevent the expression of Bid, t-Bid, Cyc and Caspase-9. The myocardial mitochondrial membrane potential of CLP group decreased after CLP surgery, while the mitochondrial membrane potential of SFI group increased significantly. Compared with the CLP group, in SFI group, the Z-line of the sarcomere was clear and distinguishable, and swollen mitochondria were significantly improved. CONCLUSIONS: The present study demonstrated that SFI improved survival rate and cardiac function of septic mice mainly by suppressing inflammation and apoptosis.
引用
- Huang P, Guo Y, Hu X, et al. Mechanism of Shenfu injection in suppressing inflammation and preventing sepsis-induced apoptosis in murine cardiomyocytes based on network pharmacology and experimental validation. J Ethnopharmacol. 2023. PMID: 38158102. doi:10.1016/j.jep.2023.117599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。